Results 211 to 220 of about 13,096 (251)
A Comprehensive Review of Phototherapy in Atopic Dermatitis: Mechanisms, Modalities, and Clinical Efficacy. [PDF]
CureusMolla A.
europepmc +1 more source
Vitiligo: From mechanisms of disease to treatable pathways. [PDF]
Skin Health DisPathak GN +4 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Dermatologic Clinics, 1995
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
Khosrow Momtaz-T +2 more
openaire +2 more sources
The goal of photochemotherapy in psoriasis is to attempt to lower the number of exposures and the total cumulative doses while still maintaining good control of the disease. PUVA has been modified by using better psoralen preparations and more effective light sources, and it also has been combined with other treatment modalities.
Khosrow Momtaz-T +2 more
openaire +2 more sources
PUVA-induced melanocytic atypia: Is it confined to PUVA lentigines?
Journal of the American Academy of Dermatology, 1985Widespread lentigines in fourteen patients following long-term therapy with psoralens and ultraviolet A (PUVA) for psoriasis were documented by biopsy of a representative lesion in a non-sun-exposed site. Chronically PUVA-exposed nonlesional skin was examined in ten of the fourteen patients.
Hollis Reid +3 more
openaire +3 more sources
Documenta Ophthalmologica, 1983
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
H G Ten-Jet-Foei, C A Geldof, C C Sterk
openaire +3 more sources
A study was made of patients, who were receiving PUVA therapy for psoriasis, to see if lens abnormalities occurred which could be due to the PUVA treatment. In a group of 42 patients there was only one eye of one patient, in which a very slight opacity was found which might possibly have developed during the therapy.
H G Ten-Jet-Foei, C A Geldof, C C Sterk
openaire +3 more sources
Cryotherapy of PUVA lentigines
British Journal of Dermatology, 1996PUVA lentigines do not subside after discontinuation of photochemotherapy. Cryotherapy with liquid nitrogen was done on a small area in a patient who presented with numerous PUVA lentigines. Five years after this treatment, the PUVA lentigines had not returned. Cosmetically disturbing PUVA lentigines can be treated with cryotherapy.
Anne Dompmartin +3 more
openaire +3 more sources
PUVA treatment of scleromyxoedema
British Journal of Dermatology, 1984Treatment of a 60-year-old woman with scleromyxoedema with 8-methoxypsoralen and UV-A radiation (PUVA) resulted in significant clinical and histological improvement but no change in circulating paraprotein.
P.M. Farr, F.A. Ive
openaire +3 more sources
Dermatologic Clinics, 1995
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +3 more sources
The development in 1974 of psoralen photochemotherapy (PUVA) for severe psoriasis transformed the therapeutic setting for this disease from in-patient to ambulatory, presaging the trend in the past decade to reduce hospitalization. The prospective evaluation of this treatment in well-designed, well-controlled studies with the participation of a large ...
openaire +3 more sources
JAMA: The Journal of the American Medical Association, 1981
Five years ago a new form of systemic therapy for psoriasis was introduced. 1 The treatment combines the oral injestion of methoxsalen followed by increasing light (long-wave ultraviolet light [UVA]) given in special phototherapy boxes in established centers. This outpatient form of therapy has proved highly effective in two large cooperative studies 2,
openaire +3 more sources
Five years ago a new form of systemic therapy for psoriasis was introduced. 1 The treatment combines the oral injestion of methoxsalen followed by increasing light (long-wave ultraviolet light [UVA]) given in special phototherapy boxes in established centers. This outpatient form of therapy has proved highly effective in two large cooperative studies 2,
openaire +3 more sources